Sharp Minds, Ordinary Genes: The Superager Mystery

Key takeaways

• In one of the largest studies of its kind, 142 "SuperAgers"—people in their 80s and 90s with memory as sharp as adults decades younger—were compared against 89 older adults with average cognitive performance.

• Standard genetic risk markers, including the well-known APOE gene and broader polygenic risk scores built from thousands of variants, could not distinguish the two groups.

• The takeaway: exceptional memory in later life likely isn't just about winning a genetic lottery—it points to still-unknown protective factors in lifestyle, biology, and environment.

Redefining what makes a SuperAger

For nearly 20 years, researchers have studied a rare group of older adults known as SuperAgers: people who reach their 80s and 90s while holding onto memory abilities that rival those of people 20 or 30 years younger. One long-standing question has been whether these individuals simply inherited a lighter genetic load—fewer of the common risk variants tied to age-related memory decline. If that were the whole story, spotting a SuperAger might be as simple as running a genetic panel rather than conducting the detailed cognitive evaluations researchers currently rely on.

This new analysis, one of the largest prospectively enrolled SuperAging cohorts studied with the latest genetic risk tools, set out to test that idea directly. Researchers drew 142 SuperAgers and 89 older adults with average cognitive performance from five research sites across the United States and Canada.

What the genetic data actually showed

Using blood samples, the team examined the APOE gene, calculated three separate polygenic risk scores combining thousands of genetic variants, and screened for rare variants previously linked to cognitive resilience. Across every one of these measures, SuperAgers looked essentially the same as the comparison group. There was no meaningful genetic signature—common or rare—separating the two groups.

In other words, the common genetic tools researchers currently use to estimate cognitive risk simply don't explain why some people's memories hold up so well. As one of the study's co-senior authors put it, this establishes an important boundary: genetics alone isn't the story here, and future research needs to look elsewhere.

A longevity lens: beyond the genetic blueprint

This finding matters for how we think about brain health over the long run. For years, aging research has leaned heavily on identifying risk factors—genetic and otherwise—that predict decline. But the absence of risk factors isn't the same as the presence of protective ones. A SuperAger's genome may look ordinary, yet something about their biology, habits, relationships, or environment is doing real protective work.

That reframes the question in a useful way. Rather than asking "did this person get lucky with their genes," the more productive question becomes: what daily patterns, environments, and social connections are compounding over decades to preserve cognitive sharpness? Genetics sets a starting point, but it doesn't appear to be the deciding factor for who ends up with a remarkably youthful memory in their 80s and 90s.

Where the research goes next

Researchers now plan a broader, multidisciplinary approach that goes well beyond DNA—combining detailed cognitive testing, brain imaging, blood biomarkers, immune profiling, sleep and activity monitoring, and social and environmental measures. The goal is to build a fuller picture of whole-person health that might explain what genetics alone cannot.

The takeaway

Memory decline isn't an inevitable part of getting older, and this study reinforces that the explanation for who preserves their cognitive edge is more complicated—and more interesting—than a simple genetic advantage. For those of us thinking about brain health as a long game, the message is encouraging: the protective factors that matter most may be the ones we can actually influence, not just the ones we inherit.

References:

Piras, I.S., Capuano, A.W., Maher, A.C., et al. SuperAging is not the inverse of common-variant ALZ risk: evidence across genetic ancestries. Alz Research, 2026; 18(1). DOI: 10.1186/s13195-026-02124-2.